Ajit Ramalingam - Apr 29, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
SVP, Chief Accounting Officer
Signature
/s/ Ajit Ramalingam
Stock symbol
BIO
Transactions as of
Apr 29, 2023
Transactions value $
-$43,276
Form type
4
Date filed
5/1/2023, 12:50 PM
Previous filing
Feb 14, 2023
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +277 +1596.54% $0.00 294 Apr 29, 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$43.3K -96 -32.61% $450.79 198 Apr 29, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -277 -33.33% $0.00 554 Apr 29, 2023 Bio-Rad A Common Stock 277 $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 17.3520 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.